DAVIDOW ROBERT L sold 88.5% of their position (617K shares) of AVENUE THERAPEUTICS, INC. on the open market
Open‑market sale worth $86.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 12/13/2023ACC: 0001553350-23-000471
10% Owner
Since Oct 2023
-617K
Net shares
Net seller
$86.6K
Total sold
6
Open market trades
0B · 6S
6
Total transactions
617K disposed
Non-Derivative Transactions6
Common Stock
Direct
Shares
−264K
Price / share
$0.14
Trade value
$36.96K
% of position
27.9%
12/11/2023
945K→681K
Common Stock
Indirect
Shares
−18K
Price / share
$0.15
Trade value
$2.70K
% of position
45.0%
12/11/2023
40K→22K
Common Stock
Indirect
Shares
−61K
Price / share
$0.14
Trade value
$8.54K
% of position
45.2%
12/11/2023
135K→74K
Common Stock
Indirect
Shares
−126K
Price / share
$0.14
Trade value
$17.64K
% of position
36.9%
12/11/2023
341.80K→215.80K
Common Stock
Indirect
Shares
−128K
Price / share
$0.14
Trade value
$17.92K
% of position
46.5%
12/11/2023
275K→147K
Common Stock
Indirect
Shares
−20K
Price / share
$0.14
Trade value
$2.80K
% of position
20.0%
12/11/2023
100K→80K
Total
Net shares
−617K
Net value
-$86.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2023 | S · Sale | −264K | $0.14 | $36.96K | 27.9% | 945K | 681K |
| Common Stock Indirect | 12/11/2023 | S · Sale | −18K | $0.15 | $2.70K | 45.0% | 40K | 22K |
| Common Stock Indirect | 12/11/2023 | S · Sale | −61K | $0.14 | $8.54K | 45.2% | 135K | 74K |
| Common Stock Indirect | 12/11/2023 | S · Sale | −126K | $0.14 | $17.64K | 36.9% | 341.80K | 215.80K |
| Common Stock Indirect | 12/11/2023 | S · Sale | −128K | $0.14 | $17.92K | 46.5% | 275K | 147K |
| Common Stock Indirect | 12/11/2023 | S · Sale | −20K | $0.14 | $2.80K | 20.0% | 100K | 80K |
| Total | −617K | -$86.56K | ||||||
Derivative Transactions0
No derivative transactions reported